GSK2302032A Antigen-Specific cancer Immunotherapeutic as adjuvant therapy in patients with Non-Small Cell Lung Cancer

Clinical Trial Grant

Duke Scholars

Principal Investigator David Harold Harpole Jr. Surgery, Cardiovascular and Thoracic Surgery

Awarded By

GlaxoSmithKline

Start Date

October 1, 2013

End Date

March 19, 2015

Awarded By

GlaxoSmithKline

Start Date

October 1, 2013

End Date

March 19, 2015